When ITMN announced their data for ITMN-191, they properly announced a conference call a day before to notify their investor's important data is coming and the data was releaded at 7:00am eastern. Now lets look at bad management, AspenBio comes out with a pr release at 9:15am to announce very important data for their appendicitis diagnostic test, it failed, stock down 85 percent, they did not have a conference call to investor's until the next morning. I expect when ITMN is ready to release pirfenidone data, good or bad, you will see a pr release a day early about a conference call time. Should be anyday now.
It is now going on three months since last patient visit. I honestly can't remember any trial that took three months to report top line results. One of two things is going on here. They are either totally incomptent, or are data mining the failed trials looking for some positives. Neither scenario is a good one.
Sunny, I think this week or next week at the latest we see data. By the way, you see Altus this morning, dropping Triztek, concentrating on once weekly HGH. Also this week, look for important data out of SQNM. Good luck
Dan Welch has been as good as his track record in big pharma - he's been around the launch of some big products (Plavix etc). I'm much more impressed with the other execs now that Blatt has moved on - lots of UCSF connections suggests that they are probably decent physician-scientists.
Several of the board members represent major debtholders and shareholders, so you figure they must have an investor's interest in the outcome of the R & D program.